Hyperthermia (also called thermal therapy or thermotherapy) is a type of cancer
treatment in which body tissue is exposed to high temperatures (up to 41
degrees celsius). Research has shown that high temperatures can damage and kill
cancer cells, usually with minimal injury to normal tissues. By killing cancer
cells and damaging proteins and structures within cells, hyperthermia may
Hyperthermia is almost always used with other forms of cancer therapy.
hyperthermia, heat is applied to a small area, such as a
tumor, using various techniques that deliver energy to heat the tumor.
Different types of energy may be used to apply heat, including microwave,
radiofrequency, and ultrasound. Depending on the tumor location, there are
several approaches to local hyperthermia:
hyperthermia, various approaches may be used to heat large
areas of tissue, such as a body cavity, organ, or limb.
is used to treat metastatic cancer that has spread throughout the body.
This can be accomplished by several techniques that raise the body
temperature to 107–108°F, including the use of thermal chambers (similar
to large incubators) or hot water blankets.
The effectiveness of hyperthermia treatment is related to the
temperature achieved during the treatment, as well as the length of treatment
and cell and tissue characteristics. To ensure that the desired temperature is
reached, but not exceeded, the temperature of the tumor and surrounding tissue
is monitored throughout hyperthermia treatment.
The Cocoon Wellness Pro is a personalized sauna, detox, and weight loss system designed for full body comfort and relaxation. The Cocoon POD includes both infrared (IR) and traditional dry (sauna) heat features
Unique to the sauna industry, SaunaWellness Sauna IR-PRO includes tri-spectrum infrared (IR) heating. This unique system allows the you to experience the benefits of three separate wavelengths for fast and even heating.
FAR Infrared Sauna
Our bodies have many ways of ridding itself from toxins and free
radicals that build up. One of these ways is through natural sweating. A FAR
infrared sauna penetrates the body and raises the body’s core
temperature, which in turn promotes more sweat to be formed. Because of
the penetration of the infrared technology, the sweat contains more toxins than
one would sweat out in a traditional hot rock or wet sauna.
What can I expect from a FAR infrared sauna session and
what will it do for me?
Patients who go for Far
infrared sauna sessions often experience deep relaxation
during and after a treatment
is an excellent addition to most treatments
Patients often report
better sleeping patterns after sessions
Who can get FAR infrared
FAR infrared sauna is available to anybody except pregnant women and children under
five. Always check with your healthcare provider before
starting FAR infrared sauna therapy.
How long does it take?
A standard session of far infrared sauna
takes between 35 and 45 minutes.
Book Your Appointment Today 011 718 3004 / 011 483 1080
van der Zee J. Heating the patient: A promising approach? Annals of Oncology 2002; 13:1173–1184.
Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Critical Reviews in Oncology/Hematology 2002; 43:33–56.
Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in combined treatment of cancer. The Lancet Oncology 2002; 3:487–497.
Alexander HR. Isolation perfusion. In: DeVita VT Jr., Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology. Vol. 1 and 2. 6th ed. Philadelphia: Lippincott Williams and Wilkins, 2001.
Falk MH, Issels RD. Hyperthermia in oncology. International Journal of Hyperthermia 2001; 17(1):1–18.
Dewhirst MW, Gibbs FA Jr, Roemer RB, Samulski TV. Hyperthermia. In: Gunderson LL, Tepper JE, editors. Clinical Radiation Oncology. 1st ed. New York, NY: Churchill Livingstone, 2000.
Kapp DS, Hahn GM, Carlson RW. Principles of Hyperthermia. In: Bast RC Jr., Kufe DW, Pollock RE, et al., editors. Cancer Medicine e.5. 5th ed. Hamilton, Ontario: B.C. Decker Inc., 2000.
Feldman AL, Libutti SK, Pingpank JF, et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. Journal of Clinical Oncology 2003; 21(24):4560–4567.
Chang E, Alexander HR, Libutti SK, et al. Laparoscopic continuous hyperthermic peritoneal perfusion. Journal of the American College of Surgeons 2001; 193(2):225–229.